|Articles|June 2, 2003
- Pharmaceutical Technology-06-02-2003
- Volume 27
- Issue 6
Formulation Development of a Nucleotide Phosphoramidate
Author(s)Manoj Maniar, PhD
A small-volume parenteral formulation of NB1011, an enzyme-catalyzed therapeutic activation compound, was successfully developed for intravenous administration.
Advertisement
Articles in this issue
about 23 years ago
June 2003about 23 years ago
From Genome Exploration to Drug Developmentabout 23 years ago
Are you ready for Gen3about 23 years ago
Outsourcing OutlookAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer
4
Why the First Generic Single-Dose Flu Antiviral Approval Matters
5